The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm. Zafar A, Drobni ZD, Lei M, Gongora CA, et al. PLoS One 2022;17:e0265767.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zafar A, Drobni ZD, Lei M, Gongora CA, et al. The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm. PLoS One 2022;17:e0265767.
PMID: 35390017